Arteris Major Shareholder Sells $582K in Stock

Bayview Legacy, LLC reduces stake in semiconductor IP company Arteris

Mar. 12, 2026 at 2:04pm

Got story updates? Submit your updates here. ›

Bayview Legacy, LLC, a major shareholder of Arteris, Inc. (NASDAQ:AIP), sold 41,000 shares of the company's stock on March 9 at an average price of $14.21, for total proceeds of $582,610. The firm then sold an additional 9,000 shares on March 10, bringing the total insider sales to 50,000 shares (~$714,550) and trimming Bayview Legacy's holding to 9,238,071 shares, a 0.44% decrease.

Why it matters

Insider selling activity, especially by major shareholders, can be a signal of changing sentiment or future performance concerns. Arteris is a semiconductor IP company, so its stock performance is closely watched by investors in the technology and electronics sectors.

The details

Arteris, Inc. is a fabless semiconductor intellectual property (IP) company that specializes in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. Bayview Legacy, LLC's sale of 50,000 Arteris shares represents a 0.44% decrease in its overall stake in the company.

  • On March 9, Bayview Legacy, LLC sold 41,000 Arteris shares at an average price of $14.21.
  • On March 10, Bayview Legacy, LLC sold an additional 9,000 Arteris shares.

The players

Bayview Legacy, LLC

A major shareholder of Arteris, Inc. that sold a portion of its stake in the semiconductor IP company.

Arteris, Inc.

A fabless semiconductor intellectual property company that specializes in on-chip interconnect solutions and system IP for advanced integrated circuits.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

The insider selling activity by a major Arteris shareholder may raise some concerns among investors about the company's near-term prospects or the major holder's confidence in the stock. However, the company's recent quarterly results showing better-than-expected performance could help offset these concerns.